References
1.
Segal ZV, Williams JMG, Teasdale JD: Mindfulness-Based Cognitive Therapy for Depression, ed 2. New York, Guilford Press, 2013.
2.
Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, Hayes R, Huijbers M, Ma H, Schweizer S, Segal Z, Speckens A, Teasdale JD, Van Heeringen K, Williams M, Byford S, Byng R, Dalgleish T: Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry 2016; 73: 565–574.
3.
Piet J, Hougaard E: The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 2011; 31: 1032–1040.
4.
van der Velden AM, Kuyken W, Wattar U, Crane C, Pallesen KJ, Dahlgaard J, Fjorback LO, Piet J: A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder. Clin Psychol Rev 2015; 37: 26–39.
5.
Timm C, Ubl B, Zamoscik V, Ebner-Priemer U, Reinhard I, Huffziger S, Kirsch P, Kuehner C: Cognitive and affective trait and state factors influencing the long-term symptom course in remitted depressed patients. PLoS One 2017; 12:e0178759.
6.
Wichers M, Peeters F, Geschwind N, Jacobs N, Simons CJP, Derom C, Thiery E, Delespaul PH, van Os J: Unveiling patterns of affective responses in daily life may improve outcome prediction in depression: a momentary assessment study. J Affect Dis 2010; 124: 191–195.
7.
Garland EL, Geschwind N, Peeters F, Wichers M: Mindfulness training promotes upward spirals of positive affect and cognition: multilevel and autoregressive latent trajectory modeling analyses. Front Psychol 2015; 6: 15.
8.
Malinowski P: Neural mechanisms of attentional control in mindfulness meditation. Front Neurosci 2013; 7: 8.
9.
Koster EHW, De Lissnyder E, Derakshan N, De Raedt R: Understanding depressive rumination from a cognitive science perspective: the impaired disengagement hypothesis. Clin Psychol Rev 2011; 31: 138–145.
10.
Vittengl JR: Poorer long-term outcomes among persons with major depressive disorder treated with medication. Psychother Psychosom 2017; 86: 302–304.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.